Press release
Generic Drugs - Top Companies Regional and Data Analysis to 2031
Generic drugs are pharmaceutical products that contain the same active ingredient, in the same strength, dosage form, and route of administration, as their corresponding brand-name medications. They are required to demonstrate bioequivalence, ensuring comparable safety, efficacy, and therapeutic performance. Although they may differ in color, shape, or inactive components, their clinical effect remains the same. Generic drugs undergo rigorous regulatory evaluation and quality testing before approval. They typically enter the market after the expiration of patents and exclusivity of the original drug, allowing for lower development costs and consequently reduced pricing for patients and healthcare systems.Download Sample PDF Copy https://www.theinsightpartners.com/sample/TIPRE00003414/?utm_source=OpenPR&utm_medium=10826
The List of Companies
• Teva Pharmaceutical Industries Ltd
• Viatris Inc
• Dr. Reddy's Laboratories Ltd
• Novartis AG
• Sun Pharmaceutical Industries Ltd
• AbbVie Inc
• AstraZeneca Plc
• Sanofi SA
• Aurobindo Pharma Ltd
• Glenmark Pharmaceuticals Ltd.
Contact Us:
If you have any queries about this report or if you would like further information, please get in touch with us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in: 日本 | 한국어 | Français | لعربية< | 中文 | Italiano | Español | Deutsch
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Drugs - Top Companies Regional and Data Analysis to 2031 here
News-ID: 4285322 • Views: …
More Releases from The Insight Partners
Sports Nutrition Market Size to reach a revised size US$ 46.41 billion by 2031 | …
The sports nutrition market size is projected to reach US$ 46.41 billion by 2031 from US$ 24.01 billion in 2023. The market is expected to register a CAGR of 8.6% during 2023-2031. The increasing number of vegan consumers worldwide boosts the demand for sports nutrition products with vegan, organic, and plant-based ingredients. The growing awareness among consumers about plant-based sports nutrition products being more nutritious than traditional products is expected…
Wire-to-Wire EV Connectors Market Set for Robust Growth Driven by EV Electrifica …
The Wire-to-Wire EV Connectors Market is poised for significant expansion over the next decade as electric vehicle (EV) adoption accelerates globally. According to the latest market insights, the market was valued at US$ 1,247.98 million in 2024 and is expected to reach US$ 5,773.76 million by 2031. The wire-to-wire EV connectors market is estimated to register a CAGR of 24.7% during 2025-2031. This growth trajectory is underpinned by the growing…
Rising Demand for Marine Infrastructure & Coastal Management Accelerates Growth …
November 24, 2025 - According to The Insight Partners; The global hydrographic survey market is witnessing strong momentum as governments, maritime authorities, and private organizations increasingly prioritize coastal safety, offshore resource exploration, and sustainable marine infrastructure development. As international maritime trade continues to expand, hydrographic surveys have become indispensable for ensuring safe navigation, accurate seabed mapping, and effective marine spatial planning.
Check valuable insights in the hydrographic survey Market report. You…
Angioplasty Balloons Market Poised for 3.6% CAGR Growth Through 2030
The Global Angioplasty Balloons Market is undergoing significant transformation as healthcare providers and patients increasingly seek minimally invasive cardiovascular treatments. In 2025 and beyond, industry participants, clinicians, and policy makers are responding to trends such as aging populations, regional infrastructure developments, and innovation in device technology.
Check valuable insights in the Angioplasty Balloons Market report. You can easily get a sample PDF of the report - https://www.theinsightpartners.com/sample/TIPHE100001278?utm_source=OpenPr&utm_medium=10457
Angioplasty Balloons Market: Elevating Cardiovascular…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
